Could chemo after surgery stop pancreatic tumor return?

This phase 3 trial tests whether adding chemotherapy after surgery can prevent aggressive pancreatic neuroendocrine tumors from coming back. About 300 patients will either receive active surveillance alone or 6 cycles of capecitabine-temozolomide pills plus surveillance. The study aims to see if chemo improves disease-free survival without a cure, as ongoing management is still needed.